methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate

C49H50N8O7 — CID 144563346

IUPACmethyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate
SMILESCOC(=O)NC(C(=O)N1C2CC2C[C@H]1c1nc2ccc(-c3ccc(-c4ccc(-c5cnc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]5)cc4)c4c5ccc(o5)c34)cc2[nH]1)=C(C)C
InChIInChI=1S/C49H50N8O7/c1-24(2)42(54-48(60)62-5)46(58)56-19-7-8-35(56)44-50-23-34(53-44)27-11-9-26(10-12-27)30-14-15-31(41-39-18-17-38(64-39)40(30)41)28-13-16-32-33(20-28)52-45(51-32)37-22-29-21-36(29)57(37)47(59)43(25(3)4)55-49(61)63-6/h9-18,20,23-24,29,35-37,42H,7-8,19,21-22H2,1-6H3,(H,50,53)(H,51,52)(H,54,60)(H,55,61)/t29?,35-,36?,37-,42-/m0/s1
InChIKeyCLRKESSQEQWJSM-UZOWZNPSSA-N
MW862.99 g/mol
LogP8.98
Rot. Bonds10

About methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate

methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate (PubChem CID 144563346) has the molecular formula C49H50N8O7 and a molecular weight of 862.99 g/mol. Its IUPAC name is methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate.

Molecular Properties

Compound Namemethyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate
PubChem CID144563346
Molecular FormulaC49H50N8O7
Molecular Weight862.99 g/mol
Exact Mass862.38
IUPAC Namemethyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate
SMILESCOC(=O)NC(C(=O)N1C2CC2C[C@H]1c1nc2ccc(-c3ccc(-c4ccc(-c5cnc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]5)cc4)c4c5ccc(o5)c34)cc2[nH]1)=C(C)C
InChIInChI=1S/C49H50N8O7/c1-24(2)42(54-48(60)62-5)46(58)56-19-7-8-35(56)44-50-23-34(53-44)27-11-9-26(10-12-27)30-14-15-31(41-39-18-17-38(64-39)40(30)41)28-13-16-32-33(20-28)52-45(51-32)37-22-29-21-36(29)57(37)47(59)43(25(3)4)55-49(61)63-6/h9-18,20,23-24,29,35-37,42H,7-8,19,21-22H2,1-6H3,(H,50,53)(H,51,52)(H,54,60)(H,55,61)/t29?,35-,36?,37-,42-/m0/s1
InChIKeyCLRKESSQEQWJSM-UZOWZNPSSA-N
XLogP8.98
TPSA187.78 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds10
Heavy Atoms64
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500862.99
LogP ≤ 58.98
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate?
The IUPAC name of methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate (CID 144563346) is methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate.
What is the SMILES notation for methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate?
The canonical SMILES for methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate is COC(=O)NC(C(=O)N1C2CC2C[C@H]1c1nc2ccc(-c3ccc(-c4ccc(-c5cnc([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]5)cc4)c4c5ccc(o5)c34)cc2[nH]1)=C(C)C.
What is the InChIKey of methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate?
The InChIKey is CLRKESSQEQWJSM-UZOWZNPSSA-N. The full InChI is InChI=1S/C49H50N8O7/c1-24(2)42(54-48(60)62-5)46(58)56-19-7-8-35(56)44-50-23-34(53-44)27-11-9-26(10-12-27)30-14-15-31(41-39-18-17-38(64-39)40(30)41)28-13-16-32-33(20-28)52-45(51-32)37-22-29-21-36(29)57(37)47(59)43(25(3)4)55-49(61)63-6/h9-18,20,23-24,29,35-37,42H,7-8,19,21-22H2,1-6H3,(H,50,53)(H,51,52)(H,54,60)(H,55,61)/t29?,35-,36?,37-,42-/m0/s1.
What are the key properties of methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate?
methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate has a molecular weight of 862.99 g/mol, XLogP of 8.98, 10 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for methyl N-[1-[(3S)-3-[6-[6-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]-11-oxatricyclo[6.2.1.02,7]undeca-1(10),2,4,6,8-pentaen-3-yl]-1H-benzimidazol-2-yl]-2-azabicyclo[3.1.0]hexan-2-yl]-3-methyl-1-oxobut-2-en-2-yl]carbamate is sourced from PubChem (CID 144563346), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).